Achieve Life Sciences Inc (SP4P) - Total Liabilities

Latest as of March 2026: €22.43 Million EUR ≈ $26.22 Million USD

Based on the latest financial reports, Achieve Life Sciences Inc (SP4P) has total liabilities worth €22.43 Million EUR (≈ $26.22 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Achieve Life Sciences Inc (SP4P) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Achieve Life Sciences Inc - Total Liabilities Trend (2016–2025)

This chart illustrates how Achieve Life Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Achieve Life Sciences Inc asset portfolio.

Achieve Life Sciences Inc Competitors by Total Liabilities

The table below lists competitors of Achieve Life Sciences Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Zhejiang Tiancheng Control Co SHG:603085	China	CN¥2.57 Billion
Guangxi Nanning Waterworks Co SHG:601368	China	CN¥21.35 Billion
Franklin BSP Realty Trust Inc NYSE:FBRT	USA	$4.82 Billion
Wheels India Limited NSE:WHEELS	India	Rs23.31 Billion
SeaBird Exploration Plc OL:SBX	Norway	Nkr20.23 Million
Konka Group Co Ltd SHE:000016	China	CN¥24.50 Billion
Anhui Huamao Textile Co Ltd SHE:000850	China	CN¥2.71 Billion
ShenZhen Zero-Seven Co Ltd SHE:000007	China	CN¥173.46 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Achieve Life Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SP4P net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.62	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.10	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.68	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Achieve Life Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Achieve Life Sciences Inc (2016–2025)

The table below shows the annual total liabilities of Achieve Life Sciences Inc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	€20.27 Million ≈ $23.70 Million	+14.31%
2024-12-31	€17.73 Million ≈ $20.73 Million	-14.82%
2023-12-31	€20.82 Million ≈ $24.34 Million	-3.92%
2022-12-31	€21.67 Million ≈ $25.33 Million	+11.27%
2021-12-31	€19.47 Million ≈ $22.77 Million	+546.55%
2020-12-31	€3.01 Million ≈ $3.52 Million	-0.53%
2019-12-31	€3.03 Million ≈ $3.54 Million	-7.74%
2018-12-31	€3.28 Million ≈ $3.84 Million	+63.04%
2017-12-31	€2.01 Million ≈ $2.35 Million	-76.33%
2016-12-31	€8.50 Million ≈ $9.94 Million	--

About Achieve Life Sciences Inc

F:SP4P Germany Biotechnology

Market Cap

$828.13 Million

€708.35 Million EUR

Market Cap Rank

#11630 Global

#1301 in Germany

Share Price

€6.90

Change (1 day)

+6.98%

52-Week Range

€2.29 - €7.25

All Time High

€5709.00